Nearly one in five American teenage boys is diagnosed with attention deficit hyperactivity disorder, marking a dramatic rise in the past decade, the New York Times reported on Monday. The condition, for which potent stimulant drugs like Adderal or Ritalin are often prescribed, has been previously estimated to affect three to seven percent of children. The newspaper compiled the data from raw figures provided by the Center for Disease Control and Prevention, which took a phone survey of 76,000 parents from 2011 to 2012. The report said that 15 percent of school-age boys in the United States have received an ADHD diagnosis, compared to seven percent among girls. Among those age 14 to 17, the rate was higher: 19 percent for boys and 10 percent for girls. An estimated 6.4 million children ages 4 through 17 have received an ADHD diagnosis at some point in their lives, a 16 percent increase since 2007 and a 53 percent rise in the past decade, the newspaper said. Experts said the figures were surprising and raised concern about the potential for abuse of the medications used to treat ADHD, as well as risks of misuse including psychosis, anxiety and addiction. “We need to ensure balance,” CDC director Thomas Frieden was quoted as saying. “The right medications for ADHD, given to the right people, can make a huge difference. Unfortunately, misuse appears to be growing at an alarming rate.” James Swanson, a professor of psychiatry at Florida International University and a leading ADHD researcher, expressed concern about the findings. “There’s no way that one in five high-school boys has ADHD,” he was quoted as saying. “If we start treating children who do not have the disorder with stimulants, a certain percentage are going to have problems that are predictable — some of them are going to end up with abuse and dependence.” The newspaper also noted that sales of stimulants that treat ADHD have more than doubled in recent years. In 2007, sales amounted to four billion dollars; in 2012 they were to nine billion dollars.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor